BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31199560)

  • 1. Identification of potential diagnostic biomarkers for Parkinson's disease.
    Jiang F; Wu Q; Sun S; Bi G; Guo L
    FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
    Wang C; Chen L; Yang Y; Zhang M; Wong G
    Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.
    Kong P; Lei P; Zhang S; Li D; Zhao J; Zhang B
    Neurosci Lett; 2018 Jan; 662():51-58. PubMed ID: 28965931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling predicts pathways and genes associated with Parkinson's disease.
    Liu S; Zhang Y; Bian H; Li X
    Neurol Sci; 2016 Jan; 37(1):73-79. PubMed ID: 26269422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
    Li T; Tang W; Zhang L
    Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Ge WH; Lin Y; Li S; Zong X; Ge ZC
    J Cell Biochem; 2018 Jan; 119(1):650-658. PubMed ID: 28636181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.
    Hossein-Nezhad A; Fatemi RP; Ahmad R; Peskind ER; Zabetian CP; Hu SC; Shi M; Wahlestedt C; Zhang J; Faghihi MA
    J Parkinsons Dis; 2016; 6(1):109-17. PubMed ID: 26889637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression Rate Associated Peripheral Blood Biomarkers of Parkinson's Disease.
    Fan Y; Xiao S
    J Mol Neurosci; 2018 Jul; 65(3):312-318. PubMed ID: 29936662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of distinct blood-based biomarkers in early stage of Parkinson's disease.
    Wu Y; Yao Q; Jiang GX; Wang G; Cheng Q
    Neurol Sci; 2020 Apr; 41(4):893-901. PubMed ID: 31828678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression meta-analysis of Parkinson's disease and its relationship with Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Albani D; Li X
    Mol Brain; 2019 Feb; 12(1):16. PubMed ID: 30819229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying distinct candidate genes for early Parkinson's disease by analysis of gene expression in whole blood.
    Sun AG; Wang J; Shan YZ; Yu WJ; Li X; Cong CH; Wang X
    Neuro Endocrinol Lett; 2014; 35(5):398-404. PubMed ID: 25275262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pathogenic genes and upstream regulators in age-related macular degeneration.
    Zhao B; Wang M; Xu J; Li M; Yu Y
    BMC Ophthalmol; 2017 Jun; 17(1):102. PubMed ID: 28651595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.